Log in
Enquire now
‌

US Patent 11161802 L-ornithine phenyl acetate and methods of making thereof

Patent 11161802 was granted and assigned to Ocera Therapeutics on November, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Ocera Therapeutics
Ocera Therapeutics
0
Current Assignee
Ocera Therapeutics
Ocera Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
111618020
Patent Inventor Names
Stephen William Watt0
Keith Anderson0
Peter Manini0
Attilia Figini0
Christine Henderson Dougan0
Jim Behling0
Date of Patent
November 2, 2021
0
Patent Application Number
202001310
Date Filed
January 31, 2020
0
Patent abstract

Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11161802 L-ornithine phenyl acetate and methods of making thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.